Wayland Group(OTC) MRRCF

Wayland Group Corp. specializes in the cultivation and sale of both medical and recreational cannabis products, serving patients and consumers across Canada and internationally. Established in 2013, the company operates under several distinct brands, offering a diverse selection of cannabis strains.

Products and Services

• Medical and recreational cannabis products
• Diverse cannabis strains with varying CBD and THC levels
• Brands include Kiwi, Northern Harvest, and High Tide

Growth Outlook

• Expanding product portfolio to meet diverse consumer needs
• Increasing demand for cannabis products in international markets
• Focus on enhancing operational efficiencies to drive profitability

Financial Highlights

• Market capitalization of $2,121, indicating potential for growth
• Current ratio of 3.90, suggesting strong liquidity position
• Debt ratio of 0.25, reflecting manageable debt levels

Wayland Group Corp. is positioned in the growing cannabis industry, with a focus on both medical and recreational markets. The company's diverse product offerings cater to a wide range of consumer preferences, which is crucial in a competitive landscape. The growth outlook remains positive, driven by increasing demand and a commitment to operational efficiency. Financially, the company demonstrates a solid liquidity position, as indicated by a current ratio of 3.90, which suggests it can cover short-term obligations effectively. Additionally, a manageable debt ratio of 0.25 indicates a balanced approach to leveraging resources for growth. Overall, Wayland Group Corp. presents an intriguing opportunity for investors interested in the evolving cannabis sector.